Cryopreservation Equipment Market, Segmentation by Equipment

The Cryopreservation Equipment Market has been segmented by Equipment into Freezers - Cryopreservation Freezers and Drystore Freezers, Incubators, Sample Preparation Systems & Accessories - Cryopreservation Vials , Freezer Box, Cryocart, Cryogenic Vaporizer, and Others.

Freezers (Cryopreservation Freezers and Drystore Freezers)

Freezers are the leading equipment category in the cryopreservation equipment market, comprising nearly 48% of global sales. Cryopreservation freezers offer ultra-low temperature storage critical for preserving cells, tissues, and genetic materials, while drystore freezers provide safe, long-term storage without ice contamination. Their central role in biobanking, stem cell research, and fertility preservation ensures strong market demand across clinical and research settings.

Incubators

Incubators hold a 19% market share and are essential for ensuring controlled environmental conditions during sample handling, thawing, or cell culture preparation. With precise regulation of temperature, humidity, and CO₂ levels, incubators are widely used in cell therapy labs, IVF clinics, and pharmaceutical R&D.

Sample Preparation Systems & Accessories

Sample preparation systems and accessories contribute about 33% of the total market and include items such as cryopreservation vials, freezer boxes, cryocarts, and cryogenic vaporizers. These tools are crucial for sample integrity, safe transport, and organized storage. As biological sample volumes grow, the demand for automated, reliable storage solutions continues to rise.

Cryopreservation Equipment Market, Segmentation by Cryogen

The Cryopreservation Equipment Market has been segmented by Cryogen into Cord Blood Stem Cells, Semen & Testicular Tissues, Embryos & Oocytes, and Others.

Cord Blood Stem Cells

Cord blood stem cells lead the cryopreservation equipment market by cryogen, accounting for around 36% of total usage. These stem cells are a valuable resource for treating blood and immune system disorders, and their long-term preservation supports both public and private banking initiatives. The expanding use of stem cell transplants and regenerative therapies is significantly boosting this segment’s growth.

Semen & Testicular Tissues

Semen and testicular tissue cryopreservation holds a 28% market share. It plays a crucial role in fertility preservation, particularly for men undergoing cancer treatments or facing reproductive challenges. With increasing awareness of male infertility and the expansion of sperm banks, this segment continues to experience steady demand.

Embryos & Oocytes

Embryos and oocytes make up about 25% of the market and are central to assisted reproductive technologies (ART). These cryogens support egg freezing, embryo banking, and IVF procedures, particularly for women seeking to delay childbearing or undergoing medical treatments. Improvements in vitrification techniques and clinical success rates are fueling further adoption.

Others

The Others segment, comprising roughly 11%, includes cryopreservation of tissues, bone marrow stem cells, and rare or genetically modified cell lines used in research. As personalized medicine, gene therapy, and biobanking evolve, this diverse segment is expected to witness increasing demand.

Cryopreservation Equipment Market, Segmentation by Application

The Cryopreservation Equipment Market has been segmented by Application into Cord Blood Stem Cells, Semen & Testicular Tissues, Embryos & Oocytes, and Others.

Cord Blood Stem Cells

Cord blood stem cell cryopreservation leads the cryopreservation equipment market by application, making up around 37% of global demand. These stem cells are widely used for treating blood cancers, genetic disorders, and immune deficiencies. Increasing investment in public and private cord blood banks, coupled with advancements in stem cell transplantation, continues to drive rapid growth in this segment.

Semen & Testicular Tissues

Semen and testicular tissue preservation holds a 26% market share and is essential for male fertility preservation. It is commonly used prior to chemotherapy, radiation therapy, or vasectomy. The rise in male infertility cases and the proliferation of sperm banks across emerging markets are propelling this segment forward.

Embryos & Oocytes

Embryo and oocyte cryopreservation comprises approximately 24% of the market and plays a critical role in assisted reproductive technologies (ART). It supports women undergoing IVF treatments, those choosing to delay childbearing, or preserving fertility before medical interventions. Innovations in vitrification have significantly improved survival rates and success outcomes, enhancing demand.

Others

The Others category, covering 13% of the market, includes the cryopreservation of research cell lines, engineered tissues, and experimental therapeutic materials. As regenerative medicine, personalized therapies, and cell-based research grow, this segment is gaining strategic importance across biotechnology and academic research institutions.

Cryopreservation Equipment Market, Segmentation by End Users

The Cryopreservation Equipment Market has been segmented by End Users into Stem Cells Banks, Biotechnology & Pharmaceutical Organizations , Contract Research Organizations, Stem Cell Research Laboratories, and Research & Academic Institutes.

Stem Cell Banks

Stem cell banks dominate the cryopreservation equipment market by end user, contributing nearly 34% of total demand. These banks store cord blood, placental, and peripheral blood stem cells for future therapeutic use. The growing popularity of stem cell preservation, fueled by increasing public and private investments and greater awareness of cell-based therapies, is a key driver of growth in this segment.

Biotechnology & Pharmaceutical Organizations

Biotechnology and pharmaceutical companies account for approximately 26% of the market. These organizations use cryopreservation systems to store cell lines, genetic material, and biologic drug candidates during research, development, and clinical trials. As investment in biologics, immunotherapy, and personalized medicine accelerates, their reliance on advanced storage solutions is expanding rapidly.

Contract Research Organizations (CROs)

Contract Research Organizations (CROs) hold a market share of about 18%. These third-party providers support clinical and preclinical studies by managing biological sample storage and logistics. With more biotech firms outsourcing research, CROs are becoming major end users of cryopreservation infrastructure, especially in regulated environments.

Stem Cell Research Laboratories

Stem cell research laboratories represent roughly 13% of the market. Focused on regenerative medicine, cell therapy development, and basic research, these labs require precise cryogenic storage for ongoing experimentation. Their role in translating stem cell science into clinical application continues to drive demand for advanced equipment.

Research & Academic Institutes

Research and academic institutions make up approximately 9% of global demand. These facilities use cryopreservation equipment in educational programs, life sciences research, and collaborative projects. Increased funding from governments and institutions for biomedical research is supporting adoption in this segment.